Annual Review Course Webcast (2015)

Specifically designed for anyone unable to get away from the office to attend the Live Course—the Webcast option delivers the same great contentPurchase of  the Webcast features simultaneous presentation slides and audio recorded from the Live Course and includes access to online course materials.

In preparation of the American Board of Urology (ABU) Qualifying (Part 1) Examination, residents need to have basic urologic knowledge to prepare them for the ABU examinations. To fulfill this need, the American Urological Association (AUA) developed this course to disseminate current urologic knowledge. This course may also be of interest to practicing urologist preparing for the Recertification Examination as well as others, including allied health professionals, looking for a thorough review of basic urologic topics.

Target Audience

  • Residents
  • Urologists

Learning Objectives

At the conclusion of this course, participants will be able to:

  1. Apply basic, generally-accepted urological practices for superior patient care.
  2. Demonstrate core knowledge of urology necessary for Part I of the American Board of Urology (ABU) qualifying examination and for the recertification examination.
Course summary
Available credit: 
  • 25.50 AMA PRA Category 1 Credit™
  • 25.50 Non-Physician Participation
Course opens: 
06/14/2015
Course expires: 
06/14/2018
Price:
$1,295.00
Rating: 
0

PROSTATE CANCER AND BPH

  Adam S. Kibel, MD

  • Diagnosis and Screen, Staging, Imaging (including PSA Screening Controversies)
  • Treatment of Localized Cancer (U.S. Stages A and B), Watchful Waiting, Radiation, Interstitial Irradiation, Surgery, Cryosurgery and Hormonal Therapy)
  • Treatment of Advanced Cancer (U.S. Stages C and D) and Treatment of Radiation Failure       
  • Evaluation and Management of BPH

ANATOMY AND EMBRYOLOGY

  Howard B. Goldman, MD, FACS

  • Applied Anatomy
  • Embryology

PEDIATRIC UROLOGY

 Martin A. Koyle, MD

  Pediatric Urological Oncology

  • Wilm’s Tumor and Other Renal Tumors
  • Rhabdomyosarcoma
  • Neuroblastoma
  • Testis Tumors

 Andrew J. Kirsch, MD

 Voiding Dysfunction, Neurogenic & Other Bladder (Exstrophy) and UTI

 Martin A. Koyle, MD

  Disorders of the Genitalia

  • Intersex
  • Hypospadias
  • Epispadias-Exstrophy
  • Undescended Testicle, Hydroceles, Hernias

 Andrew J. Kirsch, MD   

   Congenital Urinary Tract Abnormalities

  • UPJ Obstruction, UVI Obstruction (megaureter)
  • Ureteroceles
  • Cystic Disease
  • Posterior Urethral Valves
  • Prune Belly Syndrome
  • Vesicoureteral Reflux

 Pediatric Case Studies

 Martin A. Koyle, MD and Andrew J. Kirsch, MD

PATHOLOGY PRACTICE TEST

 Donna E. Hansel, MD, PhD

AUA CHOOSING WISELY

J. Christian Winters, MD, FACS

ADRENAL

Jay T. Bishoff, MD

  • Epidemiology, Diagnosis and Imaging (including Cushings, Hyperaldosteronism, Pheochromocytoma, Cancer and the Incidentally Found Adrenal Mass)
  • Management (including Pheochromocytoma, Cancer, Hyperaldosteronism, Incidentaloma and Metastatic Disease)

FEMALE UROLOGY, URODYNAMICS AND NEUROUROLOGY

 Stephen R. Kraus, MD

  • Urodynamics Review
  • Neurourology

 Howard B. Goldman, MD, FACS

  • Overactive Bladder/Urgency Incontinence
  • Stress Urinary Incontinence
  • Pelvic Organ Prolapse
  • Vaginal Masses/Urethral Diverticulum
  • Urinary Fistula

Incontinence Case Studies (Panel)

Stephen R. Kraus, MD and Howard B. Goldman, MD, FACS

UROLITHIASIS

 Glenn M. Preminger, MD

  •  Epidemiology, Pathophysiology
  •  Evaluation and Medical Management

UROLITHIASIS (cont.)

 Peter G. Schulam, MD

  • Surgical Management of Stone Disease

LAPAROSCOPY

Peter G. Schulam, MD

  • Physiology and Complications

RENAL AND URETERAL TUMORS

Robert G. Uzzo, MD, FACS

  • Epidemiology, Anatomy, Diagnosis and Imaging

(Including Evaluation of Renal Masses)

  • Treatment of Localized Disease (including Role of Partial Nephrectomy)
  • Treatment of Metastatic Disease
  • Transitional Cell Carcinoma

INFECTION AND INFLAMMATION

 Daniel A. Shoskes, MD

  • Interstitial Cystitis
  • Sexually Transmitted Diseases (Gonorrhea, Chlamydia, AIDS and others)

URINARY TRACT INFECTION        

 John N. Krieger, MD

RENAL MEDICINE

Daniel A. Shoskes, MD

  • Renal Transplantation
  • Renal Vascular Disease
  • Renal Physiology (including Fluid and Electrolytes)

PENILE AND URETHRAL CANCER

    Robert G. Uzzo, MD, FACS,

  • Epidemiology
  • Diagnosis and Staging
  • Imaging and Treatment

UROLOGIC TRAUMA

Allen F. Morey, MD                     

  • Renal and Ureteral Trauma: Evaluation and Management
  • Bladder and Urethral Trauma: Evaluation and Management
  • Genital Trauma: Evaluation and Management

TESTICULAR TUMORS

  Wade J. Sexton, MD

  • Epidemiology, Diagnosis, Staging and Imaging (including the Role of Markers and CIS)
  • Treatment of Seminoma
  • Treatment of Non-seminomatous Germ Cell Tumors (including Controversy Regarding Stage A Management, Risk Factors for Recurrence, Algorithms for Stages A,B, and C)

RADIOLOGY PRACTICE TEST

Rosaleen Parsons, MD

BLADDER CANCER

Ashish M. Kamat, MD, MBBS, FACS

  • Epidemiology, Anatomy, Diagnosis and Imaging
  • Treatment of NMIBC/ Superficial Disease Managment
  • Bladder Cancer test questions

BLADDER CANCER

Seth P. Lerner, MD, FACS

  • Management of Invasive and Advanced Disease (including Muscle Invasive Disease, Disease into Fat, Metastases Diagnosed on Staging, Bladder Salvage and the Use of Radiation and Surgery)
  • Alternate Methods of Urinary Diversion

ERECTILE DYSFUNCTION

Lawrence S. Hakim, MD

  • Physiology of Erection, Pathophysiology of Erectile Dysfunction
  • Evaluation and Management of Erectile Dysfunction
  • Pathophysiology, Evaluation and Management of Priapism Pathophysiology, Evaluation and Management of Peyronie’s Disease

INFERTILITY

 Paul J. Turek, MD

  • Physiology and Pathophysiology of Male Reproduction
  • Evaluation of the Infertile Male
  • Treatment of the Infertile Male (Surgical and Non-surgical)

Course Directors

  • Robert G. Uzzo, MD
  • Howard Goldman, MD

Faculty Disclosures

NameCompanyRoleFinancial
Bishoff, Jay ToddNothing to disclose
Goldman, Howard B.Johnson and JohnsonConsultant or Advisor, Meeting Participant or LecturerYes
American Medical SystemsConsultant or AdvisorYes
watsonMeeting Participant or LecturerYes
allerganMeeting Participant or LecturerYes
johnson and johnsonMeeting Participant or LecturerYes
pfizerConsultant or Advisor, Meeting Participant or LecturerYes
astellasMeeting Participant or LecturerYes
TevaConsultant or AdvisorYes
TDocConsultant or AdvisorYes
TevaConsultant or AdvisorYes
MedtronicConsultant or Advisor, Meeting Participant or Lecturer, Scientific Study or TrialYes
uroplastyConsultant or Advisor, Meeting Participant or LecturerYes
TheracoatConsultant or AdvisorYes
WellspectConsultant or AdvisorYes
CookScientific Study or TrialNo
american medical systemsConsultant or Advisor, Meeting Participant or LecturerYes
Hakim, Lawrence ScottENDO UrologyMeeting Participant or LecturerYes
Slate/AuxiliumMeeting Participant or LecturerYes
Hansel, Donna E.CelgeneConsultant or AdvisorYes
GenentechConsultant or AdvisorYes
Kamat, Ashish M.BiositeScientific Study or TrialNo
Endo PharmaceuticalsScientific Study or TrialYes
Bioniche TherapeuticsScientific Study or TrialYes
AdolorScientific Study or TrialYes
CelgeneScientific Study or TrialYes
Tetralogic PharmaceuticalsConsultant or AdvisorNo
Astra-ZenecaScientific Study or TrialNo
Precision TherapeuticsConsultant or AdvisorNo
GE HealthcareMeeting Participant or LecturerYes
Taris BiomedicalConsultant or AdvisorYes
Archimedes, Inc.Consultant or AdvisorYes
Alere, Inc.Scientific Study or TrialYes
FKDScientific Study or TrialYes
PhotocureConsultant or Advisor, Meeting Participant or LecturerYes
SanofiConsultant or Advisor, Meeting Participant or LecturerYes
CubistMeeting Participant or LecturerYes
AllerganMeeting Participant or LecturerYes
AbbottConsultant or AdvisorYes
TheralaseConsultant or Advisor, Investment InterestYes
Telesta Therapeutics Inc. (formerly Bioniche)Consultant or Advisor, Scientific Study or TrialYes
Heat BiologicsConsultant or Advisor, Scientific Study or TrialYes
Pacific Edge, LtdScientific Study or TrialYes
MerckConsultant or Advisor, Scientific Study or TrialYes
AurasenceConsultant or AdvisorYes
AdolorConsultant or Advisor, Scientific Study or TrialYes
Kibel, Adam StuartDendreonConsultant or Advisor, Meeting Participant or LecturerYes
Sanofi-AventisConsultant or Advisor, Scientific Study or TrialYes
National Cancer InstituteConsultant or AdvisorYes
SpecrumConsultant or AdvisorYes
Myriad GeneticsConsultant or AdvisorYes
Genomic HealthConsultant or AdvisorYes
Kirsch, Andrew JaredOceana TherapeuticsConsultant or Advisor, Meeting Participant or Lecturer, Scientific Study or TrialYes
 Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or TrialNo
CookOwner, Product DevelopmentYes
Salix PharmaceuticalsConsultant or Advisor, Meeting Participant or LecturerYes
Koyle, Martin A.Nothing to disclose
Kraus, Stephen R.NIDDKScientific Study or TrialNo
LaborieOther : Course Director and Teaching FacultyYes
PfizerConsultant or AdvisorYes
AllerganConsultant or AdvisorYes
MerckConsultant or AdvisorYes
AstellasConsultant or AdvisorYes
MedtronicMeeting Participant or LecturerYes
Krieger, John N.I own a number of mutual funds that invest in health care companies. I have no direct control of specific decisions..Other : see aboveYes
PfizerConsultant or Advisor, Scientific Study or TrialNo
Lerner, Seth PaulImaluxConsultant or Advisor, Scientific Study or TrialYes
TengionConsultant or Advisor, Scientific Study or TrialYes
ImaluxConsultant or Advisor, Scientific Study or TrialNo
Celek Pharmaceuticals, LLCConsultant or Advisor, Scientific Study or TrialYes
 Consultant or Advisor, Scientific Study or TrialNo
GE HealthcareConsultant or AdvisorYes
Endo PharmaceuticalScientific Study or TrialNo
CelgeneScientific Study or TrialNo
CephalonScientific Study or TrialNo
Astra ZenecaMeeting Participant or LecturerYes
TengionConsultant or Advisor, Scientific Study or TrialYes
DendreonConsultant or AdvisorYes
PhotocureConsultant or AdvisorYes
TarisConsultant or AdvisorYes
FKDScientific Study or TrialYes
TheracoatConsultant or AdvisorNo
BiocancellConsultant or AdvisorYes
GenentechConsultant or AdvisorYes
VaxxionConsultant or AdvisorYes
SitkaConsultant or AdvisorYes
NucleixConsultant or AdvisorYes
OncoGeneXConsultant or AdvisorYes
MerckConsultant or AdvisorYes
DendreonScientific Study or TrialNo
Taris BiomedicalConsultant or AdvisorYes
Morey, Allen F.AMSConsultant or Advisor, Meeting Participant or LecturerYes
Glaxo Smith KlineMeeting Participant or LecturerYes
PfizerMeeting Participant or LecturerYes
ColoplastMeeting Participant or LecturerYes
Parsons, RosaleenNothing to disclose
Preminger, Glenn M.Boston ScientificConsultant or AdvisorYes
Mission PharmacalConsultant or AdvisorYes
OlympusMeeting Participant or LecturerYes
Endourological SocietyLeadership PositionYes
UpToDateHealth PublishingYes
RetrophinConsultant or Advisor, Meeting Participant or LecturerYes
Schulam, Peter GerardChironOther : no memoryYes
OncuraMeeting Participant or LecturerYes
ACMIOwner, Product DevelopmentYes
Intuitive SurgicalInvestment InterestYes
Bard UrologicalMeeting Participant or LecturerYes
SurgiquestConsultant or AdvisorYes
Sexton, Wade JeffersNothing to disclose
Shoskes, Daniel ArthurTriurolInvestment InterestNo
Farr LabsConsultant or AdvisorYes
AstellasConsultant or AdvisorYes
Eli LillyConsultant or AdvisorYes
UracystConsultant or AdvisorYes
Turek, Paul JacobMandalMedLeadership PositionYes
Medical Board of CaliforniaConsultant or AdvisorYes
BioQuiddity, IncConsultant or Advisor, Investment InterestYes
HealthLoop.comConsultant or Advisor, Investment InterestYes
Doximity, IncConsultant or Advisor, Investment InterestYes
Fertility Planit, IncConsultant or Advisor, Investment InterestYes
Essential Beginnings, IncLeadership Position, Investment Interest, Owner, Product DevelopmentYes
Episona, IncConsultant or AdvisorYes
Uzzo, Robert G.PfizerMeeting Participant or LecturerYes
WilexScientific Study or TrialYes
JanssenMeeting Participant or LecturerYes
GSKScientific Study or TrialYes
MyriadConsultant or AdvisorYes
Winters, J. ChristianAstellas, IncConsultant or AdvisorYes
ConturaScientific Study or TrialNo
PfizerConsultant or AdvisorYes
Solace TheraScientific Study or TrialNo
AllerganConsultant or AdvisorYes
American Board of UrologyLeadership PositionNo
Society of Urodynamics, Female Pelvic Medicine and Urogential ReconstructionLeadership PositionNo
FerringConsultant or AdvisorYes
SolaceScientific Study or TrialYes
StimGuardConsultant or AdvisorYes

Method of Participation

To claim CME credit/hours of participation for each webcast, the learner must complete to pre-test view the webcast, complete the posttest, passing with 80% accuracy and submit the evaluation.

Estimated time to complete this activity: 25.50 hours

Release Date: June, 2015
Expiration Date: June, 2018

Accreditation

The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

The American Urological Association designates this enduring material for a maximum of 25.50 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Non-physician Health Professionals

The AUA is not accredited to offer credit for non-physician health professionals. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.

Evidence Based Content

It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

AUA Disclosure Policy

All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) participating in an educational activity provided by the AUA are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual's relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Resolution of Identified Conflict of Interest

All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

  • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Content Review Committee or its subgroup.
  • Limit content to evidence with no recommendations
  • Introduction of a debate format with an unbiased moderator (point-counterpoint)
  • Inclusion of moderated panel discussion
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
  • Divestiture of the relationship by faculty

Off-Label or Unapproved Use of Drugs or Devices

It is the policy of the AUA to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.

Reproduction Permission

Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the American Urological Association.

Available Credit

  • 25.50 AMA PRA Category 1 Credit™
  • 25.50 Non-Physician Participation

Accreditation Period

Course opens: 
06/14/2015
Course expires: 
06/14/2018
 
Status
Price
Title
$1,295.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.

Price

Price:
$1,295.00
Please login or register to take this course.